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Abstract
Current antiviral therapy does not cure HIV-infected individuals because the virus establishes lifelong latent infection within
long-lived memory T cells as integrated HIV proviral DNA. Here, we report a new therapeutic approach that aims to cure
cells of latent HIV infection by rendering latent virus incapable of replication and pathogenesis via targeted cellular
mutagenesis of essential viral genes. This is achieved by using a homing endonuclease to introduce DNA double-stranded
breaks (dsb) within the integrated proviral DNA, which is followed by triggering of the cellular DNA damage response and
error-prone repair. To evaluate this concept, we developed an in vitro culture model of viral latency, consisting of an
integrated lentiviral vector with an easily evaluated reporter system to detect targeted mutagenesis events. Using this
system, we demonstrate that homing endonucleases can efficiently and selectively target an integrated reporter lentivirus
within the cellular genome, leading to mutation in the proviral DNA and loss of reporter gene expression. This new
technology offers the possibility of selectively disabling integrated HIV provirus within latently infected cells.
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Introduction
The HIV epidemic continues to take an enormous toll in the lives
of people throughout the world. While effective antivirals are widely
available in developed countries, these drugs do not cure HIV, and
require lifelong therapy. In the developing world, access to these
drugs is severely limited. The single greatest advance for infected
individuals would be the ability to cure their HIV infection.
Current treatments do not cure individuals of HIV because of
the ability of HIV to establish lifelong latent infection within their
hosts. For HIV, the major reservoir of latent infection consists of
long-lived memory T cells containing integrated HIV proviral
DNA. There have been suggestions of clearing this reservoir by
inducing viral reactivation, presumably leading directly to death of
latently infected cells or to their recognition and clearance by the
immune system [1] [2]. To date, such approaches have not been
successful. Even if all infected cells could be reactivated and
eliminated, it is unclear what effects this would have on the
immune function of the host - it is possible that systemic
reactivation of HIV and widespread destruction of immune cells
might lead to more severe clinical disease or even death. The ideal
solution to the problem of HIV latency would be the ability to
eliminate or otherwise disable integrated HIV without inducing
death of infected cells, such that the latent virus is rendered
incapable of further replication and pathogenesis.
Homing endonucleases (HEs) are enzymes that specifically
target long (14–40 bp) DNA sequences and induce double-
stranded breaks (dsb) [3]. Engineered HEs with altered DNA
specificities are a promising tool for targeted gene therapy, since
the specific locus of interest could be, in theory, targeted for
cleavage and subsequently repaired by dsb-induced homologous
recombination with a provided donor template [4,5]. However, in
mammalian cells dsb are predominantly repaired through non-
homologous end-joining (NHEJ), a mechanism that does not
require a homologous DNA template [6]. Importantly, NHEJ is
mutagenic, since it joins broken ends with little or no homology,
often resulting in small deletions and/or insertions surrounding the
cleavage site [7]. This raises the possibility that an HE directed
toward integrated proviral DNA might specifically induce
mutagenesis of the viral sequences. Such mutagenesis could in
turn prevent synthesis of virus-encoded proteins, preventing viral
replication and continued pathogenesis. To evaluate this possibil-
ity, we constructed a reporter lentivirus containing the recognition
sequence for the engineered homing endonuclease Y2 I-AniI, and
evaluated the effects of Y2 I-AniI treatment on cells latently
infected with the reporter lentivirus.
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To test if HEs can target and cleave integrated lentiviral
genomes, we first developed a reporter construct with the
recognition site for the engineered HE Y2 I-AniI (which has the
same cleavage specificity as its natural counterpart I-AniI but has
been redesigned for higher activity) [8] inserted between the
translational start site and the gene encoding a short half-life GFP
reporter (Fig. 1a). Upon cleavage of the recognition site by Y2 I-
AniI, imprecise repair via NHEJ should cause small deletions and/
or insertions resulting in frame shifts, loss of the translational start
site, or disruption of essential GFP coding sequences. Thus,
successful HE attack can be monitored by loss of GFP expression.
The expression cassette was then cloned into an integrating
lentiviral vector under the SFFV promoter (Fig. 1a). The GFP
reporter protein used in this study is destabilized by fusion with the
PEST amino acid sequences from mouse ornithine decarboxylase
(MODC), allowing rapid proteosomal degradation, enhanced
protein turn over, and sensitive detection of changes in gene
expression [9]. Therefore, GFP accumulation in HEp-2 cells
transduced with the lentiviral reporter vector can only be detected
following treatment with the proteosome inhibitor MG132
(Fig. 1b and c). A tissue culture model of integrated retroviral
latency at low copy number was established by stably transducing
cells with the integrating reporter lentivirus vector, and then
cloning the cells using flow cytometry sorting and limiting dilution
(Fig. 1d). The reporter cell lines showed similar growth properties
as their parental lines and retained the ability to express GFP even
after several months in culture.
To determine whether the HE could access its target site
embedded in the integrated lentiviral genome to generate dsb and
DNA mutation, we transduced the reporter cells with a second
lentiviral vector containing the gene for either Y2 I-AniIo ri t si n a c t i v e
variant (E148D I-AniI), linked via an IRES (Figs. 1–4) or T2A linker
(Figs. 5–9) to the coding sequences of the mCherry fluorescent
marker. GFP expression was then analyzed over time by flow
cytometry. Over a 38-day period, cells expressing the active Y2 I-AniI
(clone T1H4S), but not the inactive enzyme, showed a progressive
loss of reporter GFP expression (Fig. 2a–b). Similar results were
obtained with two additional clonal reporter lines (T1D7S2 and
T2D10S) as well as the bulk uncloned reporter cell line T30BS2
(Fig. 3a); all three cell lines showed a loss of GFP expression in the
population of cells expressing the Y2 I-AniIe n z y m e .T h u s ,t h e
integrated viral sequences are accessible to Y2 I-AniI attack, with no
apparent effects due to the site of viral integration within the host
genome. Cells were able to be transduced a second time with the Y2
I-AniI-expressing lentivirus and showed good Y2 I-AniI expression
(Fig. 3b, top row), demonstrating that multiple rounds of homing
endonuclease treatment are possible.
In order to establish the genetic basis for the loss of GFP
expression observed in Y2 I-AniI expressing cells, PCR amplifica-
tion of the region containing the target site was performed using
Pfx and primers located on either side of the Y2 I-AniI recognition
sequence (Fig. 4a). Amplification was done on genomic DNA
obtained at 17 d post-transduction (dpt) from three sorted cell
populations (Fig. 4b): Y2 I-AniI-expressing cells having retained
(mCherry
+/GFP
+ or +/+) or lost (mCherry
+/GFP
2 or +/2) GFP
expression, and all cells negative for Y2 I-AniI expression
(mCherry
2/all or 2/all). First, mutation of the target site was
demonstrated by in vitro digestion of the PCR amplicon with
recombinant Y2 I-AniI enzyme. As seen in Fig. 4c, the amplicon
from cells having lost GFP expression (+/2) was almost totally
resistant to Y2 I-AniI digestion, while the majority of target site
DNA from cells retaining GFP expression (+/+) or negative for Y2
I-AniI expression (2/all) could be cleaved by Y2 I-AniI. Sequencing
of the region containing Y2 I-AniI target site from cells having lost
GFP expression revealed a series of genetic mutations, the majority
being small deletions(64.9%#30 bp),with a lessernumberof larger
deletions (4%, some over 200 bp); insertions (8.1%) or a
combination of insertion/deletions (10.8%) (Fig. 4d, GenBank
accession numbers: HQ416600 to HQ416674). These data
confirmed that the loss of GFP expression and the resistance to
Y2 I-AniI digest observed is indeed due specifically to HE-induced
mutation of the integrated proviral Y2 I-AniI target region.
Figure 1. Cell line with integrated reporter lentivirus vector. (a)
Schematic of the reporter lentivirus. (b) Immunofluorescence imaging
of cells 3 days post transduction (dpt) with reporter lentivirus, with or
without MG132 for 3 or 7 h. (c) Flow cytometry of the cells from panel b
after 7 h treatment with MG132. (d) Flow cytometry of the clonal
reporter (T1H4S) or parental (HEp-2) cell line after 5 h incubation with
(+ MG) or without (2MG) 1 mM MG132.
doi:10.1371/journal.pone.0016825.g001
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positive for reporter GFP expression (Fig. 2a). A possible
explanation is that these cells might have undergone genetic
mutations destroying the Y2 I-AniI recognition site but preserving
protein expression (for example, small deletions of 3 or 6 bp), and
thus be refractory to subsequent Y2 I-AniI attack. To evaluate this
possibility, a new set of experiments was done and sequencing
analysis of the target site compared between cells having retained
or lost GFP expression following Y2 I-AniI exposure. In this set of
experiments, reporter cells were transduced with Y2 I-AniI
expressing lentivirus, sorted for Y2 I-AniI expression 3 dpt
(Fig. 5a), passaged in culture and then sorted based on GFP
expression at 15 dpt (Fig. 5b). Sequence analysis of the target site
region for the cells having lost GFP expression yielded similar
results as described above, showing resistance to Y2 I-AniI
digestion in vitro (Fig. 5c) and mutation of Y2 I-AniI target region
(Fig. 5d, GenBank accession numbers: HQ416556 to
HQ416599). In contrast, analysis of the Y2 I-AniI target region
from residual GFP+ cells revealed that the majority of the DNA
remained sensitive to Y2 I-AniI digestion in vitro (Fig. 5c)
suggesting that the target site remained intact. Sequence analysis
showed that although a few clones presented the predicted short
deletions in multiples of 3 bp (Fig. 5e, GenBank accession
numbers: HQ416445 to HQ416555), the majority (95%) retained
the wild-type recognition sequence, and thus would be expected to
be susceptible to ongoing attack by Y2-AniI.
Figure 2. Targeting reporter gene in integrated lentivirus for mutagenesis by the homing endonuclease Y2 I-AniI. (a) Reporter (GFP)
fluorescence and Y2 I-AniI expression (mCherry fluorescence) at the indicated days following transduction of the clonal reporter cell line T1H4S with
lentiviral vector (moi of 2) expressing either the active enzyme Y2 I-AniI or the control inactive enzyme E148D I-AniI (as determined by mCherry
expression), or control cells left untransduced (no enzyme, mCherry negative). This panel shows the data from one representative sample of a
duplicate experiment. All cells were treated with 1 mM MG132 for 6 h prior to analysis. (b) Graphic representation of the data from the duplicate wells
in the experiment depicted in Fig. 2a. Shown is the percent of the homing endonuclease-expressing cells (mCherry
+ cell population) retaining
reporter GFP fluorescence. The filled and open symbols correspond to the data from the duplicate wells. The percent of GFP
+ cells was calculated as
follows: {%GFP
+ and mCherry
+ cells x 100}/{Total % of mCherry
+ cells}.
doi:10.1371/journal.pone.0016825.g002
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possibility of toxic effects. Over an extended period in culture, the
proportion of cells expressing Y2 I-AniI (mCherry+) decreased
(Fig. 2a). This was not observed in cells expressing the inactive
variant E148D I-AniI( Fig. 2a), excluding the possibility that loss
of mCherry expression was predominantly due to gene silencing.
DNA dsb in the mammalian genome triggers DNA damage
response pathways, which lead to cell cycle arrest, activation of
repair mechanisms, and, if damage is too extensive to repair,
initiation of cell death [10,11]. An early step in recruiting and
Figure 3. Targeting reporter gene in integrated lentivirus for mutagenesis using homing endonuclease in independent reporter
cell lines. (a) Flow cytometry analysis of two different clonal (T1D7S and T2D10S) and the bulk uncloned (T30BS2) reporter cell lines transduced with
lentiviral vector (moi=2) expressing either active Y2 I-AniI or inactive E148D I-AniI enzyme, or left untransduced (no enzyme). (b) Flow cytometry
analysis of GFP fluorescence and Y2 I-AniI expression (mCherry fluorescence) at the indicated days following a second transduction of T1H4S cells
with lentiviral vector expressing the active Y2 I-AniI enzyme (moi=2). All cells were treated with 1 mM MG132 for 6 h prior to analysis.
doi:10.1371/journal.pone.0016825.g003
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histone H2AX (c-H2AX) and localization of this protein into
discreet foci. These foci represent DNA dsb in a 1:1 manner and
can be used as a biomarker for DNA damage [12]. Therefore, we
investigated if Y2 I-AniI nuclease induced extensive DNA damage
(dsb), as might be observed if there were substantial cleavage of off-
target sequences. As expected, foci were more frequently observed
in cells expressing the active Y2 I-AniI than in cells expressing the
inactive variant or non-transduced cells (no enzyme) (Fig. 6a).
Multiple bright foci were rarely observed in a single cell; most
positive cells had a single bright focus. No detectable cell death was
observed in Y2 I-AniI exposed cells, even those exposed to high
levels of the enzyme (Fig. 6b–c), suggesting that toxicity of the HE
could not explain the decrease in Y2 I-AniI-expressing cells over
Figure 4. Mutagenesis of the reporter gene in integrated lentivirus following exposure to Y2 I-AniI. (a) Location of PCR primers used to
amplify the I-AniI target site in reporter lentivirus integrated within cellular genomic DNA. (b) Three cell populations were sorted from T1H4S cells
transduced with Y2 I-AniI expressing lentiviral vector at 17 dpt: Y2 I-AniI-expressing cells having retained (mCherry
+; GFP
+ or +/+) or lost (mCherry
+;
GFP
2 or +/2) GFP expression, and cells negative for Y2 I-AniI expression (mCherry
2 or 2/all). (c) PCR amplicons from the sorted cell populations
shown in (b) were either exposed (Y) to Y2 I-AniI enzyme in vitro or left unexposed (2). Full length undigested DNA (UD), digest products (DPs). The
positive control consisted of PCR product directly amplified from reporter lentiviral vector DNA. (d) Sequence analysis of PCR amplicons from the
sorted cell populations shown in (b). Left, representative mutated sequences. Top row shows wild type sequence with the I-AniI target site indicated
in green. Nucleotide insertions are indicated in blue. Right, summary of sequences analyzed. (GenBank accession numbers: HQ416600 to HQ416674).
doi:10.1371/journal.pone.0016825.g004
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proportion of cells in G2 phase compared to cells not expressing
Y2 I-AniI or cells expressing the inactive enzyme (Fig. 6d). Thus,
it appears that the cell cycle delay required for repair of HE-
induced dsb puts HE-expressing cells at a slight but reproducible
growth disadvantage in mixed cultures, compared to cells not
expressing HEs.
In the experiment described in Fig. 2, a loss of GFP expression
was observed in 50% of Y2 I-AniI-expressing cells by 24 days after
introduction of the HE. By this time, the proportion of cells still
expressing Y2 I-AniI had significantly decreased. To determine if
more complete disruption of integrated lentiviral sequences could
be obtained in a shorter period of time, the reporter cell line was
exposed to increasing amounts of Y2 I-AniI-expressing lentivirus.
At 5 dpt with higher amounts of lentivirus, nearly 100% of the cells
expressed Y2 I-AniI( Fig. 7a), and more than 70% were still
expressing at 12 dpt (Fig. 7b). By 12 dpt with the higher
transduction levels, 75-80% of Y2 I-AniI-expressing cells showed
loss of GFP fluorescence (Fig. 7b, left panels, and Fig. 7c). When
the target site DNA in those cell populations was analyzed for
susceptibility to in vitro Y2 I-AniI digestion, more complete
protection from cleavage was seen (Fig. 7d) compared to the
conditions (moi=2) used in the previous experiments (Fig. 4c).
In all the experiments described above, integrating lentivirus
vectors were used to introduce I-AniI nuclease into the target cells,
assuring high level and sustained expression of the enzyme.
However, integrating lentivirus vectors are unlikely to be
acceptable for clinical use. Therefore, we evaluated the use of a
non-integrating lentivirus vector (integration-deficient lentivirus,
IDLV) to transiently express Y2 I-AniI nuclease. After transduction
of the target reporter line with the IDLV expressing Y2 I-AniI, flow
cytometric as well as I-AniI target site DNA analysis were
Figure 5. Analysis of the residual GFP
+ cells after exposure to Y2 I-AniI. (a) FACS of T1H4S cells transduced with Y2 I-AniI expressing
lentiviral vector at 3 dpt, used in panels (panel b-e). (b) Flow cytometry and FACS analysis of the cells from (panel a) and maintained in culture up to
15 dpt. Two populations were sorted based on GFP fluorescence. (c)Y 2I - AniI digestion profiles of the PCR amplicons from cells in (panel b).
Amplicons were either unexposed to (-) or exposed to (Y) Y2 I-AniI enzyme. Full length undigested DNA (UD), digest products (DPs), control: PCR
product from reporter lentiviral vector DNA. (d) Summary of sequence analysis of the target region in GFP- cells (GenBank accession numbers:
HQ416556 to HQ416599). (e). Sequence analysis of the target region in GFP
+ cells (e, left) and DNA mutations detected in the GFP+ population (e,
right). Top row corresponds to the wild type sequence with the I-AniI target site indicated in green. Nucleotide insertions are indicated in blue.
(GenBank accession numbers: HQ416445 to HQ416555).
doi:10.1371/journal.pone.0016825.g005
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DAPI. At least 330 cells were scored for the presence of foci under a 40X objective. (b) Live/dead analysis of cells 35 dpt. Left column, flow cytometric
analysis for reporter GFP fluorescence and HE expression (mCherry fluorescence). The histograms from the middle (mCherry
+ cells only) and right
(mCherry
2 cells only) columns show the results of the live/dead analysis; dead cells with compromised membranes stain with the amine-reactive
fluorescent dye (Pacific blue). Positive control cells treated overnight with 1 mM staurosporine (STS, a cell death inducer) are shown in the bottom
row. (c) Flow cytometry analysis for activated caspase-3. T1H4S cells were transduced at the indicated moi with lentiviral vector expressing either
active Y2 I-AniI or inactive E148D I-AniI enzyme. At 3 dpt, cells were split into duplicate wells and assayed for cell death. One well for each condition
was used for flow cytometric analysis of reporter GFP fluorescence and HE expression (mCherry fluorescence) after 6 h treatment with MG132. The
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exposure to IDLV-Y2 I Ani-I, cells became transiently positive
(mcherry+) for Y2 I-AniI expression (Fig. 8a, compare top and
bottom rows) while cells exposed to integrating lentivirus (LV)
retained Y2 I-AniI expression. The analysis of the Y2 I-AniI
digestion susceptibility of the target site showed that while the
expression of Y2 I-AniI was transient, it was sufficient to lead to the
accumulation of target site sequences resistant to Y2 I-AniI
digestion (Fig. 8b). Since the proportion of resistant target sites
was relatively low, cells were repeatedly exposed to IDLV-Y2 I-
Figure 7. Mutagenesis of the reporter gene in integrated lentivirus following exposure to increasing amount of Y2 I-AniI. (a)Y 2I - AniI
expression (mCherry fluorescence) at 5 dpt and (b) reporter GFP fluorescence and Y2 I-AniI expression (mCherry fluorescence) at 12 dpt of the
reporter cell line T1H4S transduced with the indicated moi of lentiviral vector expressing either active Y2 I-AniI or inactive E148D I-AniI enzyme. The
experiments in Fig. 2–6 used LV-Y2 I-AniI and LV-E148D I-AniI at a moi of 2. (c) Graphic representation of the percent of homing endonuclease-
expressing cells (mCherry
+ cell population) having retained GFP fluorescence. The percent of GFP
+ cells was calculated as follows: {%GFP
+ and
mCherry
+ cells x 100}/{Total % of mCherry
+ cells}. (d)Y2 I-AniI digestion profiles of the PCR amplicons containing the Y2 I-AniI target region from the
unsorted cell populations of panel (b). Full length undigested DNA (UD), digest products (DPs). Numbers below the figure represent percent of
undigested full length DNA remaining after Y2 I-AniI digestion.
doi:10.1371/journal.pone.0016825.g007
second well of cells was used to assay for apoptosis by caspase-3 staining as described in Material & Methods. The positive control for apoptosis was
obtained by treating T1H4S cells left unexposed to HE-expressing lentivirus with 1 mM staurosporine STS overnight. The left column shows the GFP
and mCherry fluorescence analysis, and the middle (total cell population) and right (mCherry
+ cells only) columns present the results of the caspase-3
analysis for each condition. (d) Cell cycle analysis of T1H4S cells transduced with lentiviral vector expressing either active Y2 I-AniI or inactive E148D
I-AniI enzyme for 6 days, sorted for mCherry expression, and kept for 22 more days in culture. Cells were not treated with MG132 prior to staining and
flow cytometry analysis. Blue, mCherry
2 cells; red mCherry
+. Arrow indicates the increased delay in G2 among cells exposed to Y2 I-AniI.
doi:10.1371/journal.pone.0016825.g006
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increased. The cells exposed to IDLV-Y2 I-AniI (cells transduced
with an moi of 0.5; Fig. 8a,) were either maintained in culture or
exposed 1 (IDLV2), 2 (IDLV3) or 3 (IDLV4) additional times to
IDLV-Y2 I-AniI (moi of 0.5; Fig. 8c) before PCR amplification of
the target site region and Y2 I-AniI DNA digestion analysis. The
percentage of DNA target site resistant to Y2 I-AniI digestion
detected increased with the number of exposures to Y2 I-AniI
(Fig. 8c). This suggests that repeated exposure to transient
expression of Y2 I-AniI is capable of achieving higher percent
target site mutagenesis.
Finally, we asked whether similar results could be obtained in
latently infected T cells, since in humans, HIV establishes lifelong
latent infection within long-lived memory T cells [13]. We
therefore established a Jurkat T cell line stably transduced with
the reporter system described above. The Jurkat T reporter cells
were exposed to integrating lentiviral vector expressing either the
active or inactive form of Y2 I-AniI. Thirteen dpt, the cells were
analyzed by flow cytometry for GFP expression and Y2 I-AniI
target site DNA analysis performed on the unsorted population
exposed to the highest amount of lentivirus. Although GFP
expression in the Jurkat cells was only slightly above background, a
reduction in GFP fluorescence was observed in cells exposed to the
largest amount of lentivirus expressing Y2 I-AniI( Fig. 9a). To
confirm the ability of Y2 I-AniI to successfully target provirus in T
cells, we PCR amplified the region containing the target site. The
resulting amplicon was resistant to in vitro Y2 I-AniI digestion
(Fig. 9b), suggesting mutation of the site. Sequencing of the
amplicon demonstrated a variety of insertions and or deletions
(Fig. 9c, GenBank accession numbers: HQ432772 to HQ432804),
confirming the function of HEs in T cells.
Discussion
HIV establishes lifelong latency within memory T cells, and
thus current therapies can not eradicate the infection, even if they
successfully inhibit viral replication. The only hope for cure of
HIV infection lies in complete elimination of latently infected cells
or the integrated provirus they contain. Currently, there is no way
to selectively target and eliminate latently infected T cells. Some
studies have attempted to purge the T cell compartment by non-
specifically activating HIV within memory T cells, in hopes that
triggering viral replication would result in the destruction of
latently infected cells [1,2]. Such approaches have to date proven
unsuccessful. Even if it were possible to target and destroy latently
infected T cells with some degree of specificity, it is unclear what
effects the widespread T-cell destruction would have on the ability
of the infected individual to reconstitute an effective immune
response.
Because of the difficulties and potential dangers inherent in
targeting the latently infected cells themselves, an attractive
approach would be to selectively attack the integrated provirus
within these cells. Until recently this has been a largely
hypothetical possibility, but recent advances in the use of DNA
Figure 8. Mutagenesis of the reporter gene in integrated lentivirus following transient exposure to Y2 I-AniI. (a) Reporter GFP
fluorescence and Y2 I-AniI expression (mCherry fluorescence) at 3 and 7 dpt of the reporter cell line T1H4S transduced with the indicated moi of non
integrating (IDLV) or integrating (LV) lentiviral vector expressing active Y2 I-AniI enzyme, (b)Y 2I - AniI digestion profiles of PCR amplicons containing
the Y2 I-AniI target region obtained with the 7 dpt unsorted cells shown in panel (a). Numbers below the figure represent percent of undigested full
length DNA remaining after Y2 I-AniI digestion. In (b) and (c), full length undigested DNA (UD), digest products (DPs); the positive control (‘‘C’’)
consisted of PCR product directly amplified from reporter lentiviral vector DNA. (c) Left, transduction schedule of the reporter cell line T1H4S with non
integrating (IDLV) Y2 I-AniI expressing lentiviral vector at an moi of 0.5. Red arrows indicate the transduction time points and the blue arrow the time
of gDNA isolation from the unsorted cell populations. Right, Y2 I-AniI digestion profiles of the PCR amplicons containing the Y2 I-AniI target region
from the unsorted cell populations at day 25. Numbers below the figure represent percent of undigested full length DNA remaining after Y2 I-AniI
digestion.
doi:10.1371/journal.pone.0016825.g008
Targeting of Lentivirus by Homing Endonuclease
PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e16825modifying enzymes have brought this closer to reality. In one
approach, the Buchholz and colleagues [14] modified the Cre
recombinase to recognize sequences within the LTR of HIV strain
TZB0003. Exposure of latently infected cells to the modified
recombinase led to excision of provirus and the effective cure of
the cells. Unfortunately, the LTR sequence of strain TZB0003 is
atypical for HIV, and was chosen for these studies because of its
similarity to the DNA sequence recognized by the wild type Cre
recombinase. The corresponding LTR sequences from other HIV
strains are much more divergent from the wild type Cre
recognition sequence, and thus it is unlikely that this approach
can ever be generalized to clinically relevant HIV strains.
Although the excision of integrated provirus is conceptually
attractive, we would argue that excision of provirus is unnecessary
for the effective cure of latent HIV infection. It is well known that
the human genome is comprised in large part of the remnants of
ancient retroviral infections; yet these remnants do not cause
disease. The only prerequisite for an effective genetic cure of HIV
infection is that the integrated provirus be mutated sufficiently to
prevent production of progeny virus and continued pathogenesis.
It is in this context that we evaluated the possibility of using an
engineered homing endonuclease to specifically target integrated
provirus, leading to NHEJ and the induction of mutation.
Recently, a number of studies have focused on strategies to
reengineer HEs to recognize DNA sequences of interest, mainly
for applications in gene therapy [15,16,17,18,19,20,21,22,23].
These applications rely on repair of the HE-induced dsb via
homologous recombination with a supplied template with the
desired (usually wild-type) sequence. Unfortunately for such
studies, in mammalian cells dsb are often repaired via NHEJ, a
process prone to DNA deletions and other mutations. Here, we
have utilized the existing HE Y2 I-AniI to demonstrate that HEs
directed toward integrated proviral sequences can induce dsb and
mutation of integrated proviral DNA. Similar results could
presumably be obtained using other DNA double-strand cleaving
enzymes such as the zinc-finger nucleases (ZFNs). Indeed, ZFNs
Figure 9. Mutagenesis of the integrated lentivirus reporter gene in T cells following exposure to Y2 I-AniI. (a) Reporter GFP
fluorescence and Y2 I-AniI expression (mCherry fluorescence) at 13 dpt of a Jurkat T reporter cell line transduced with the indicated moi of lentiviral
vector expressing either active Y2 I-AniI or inactive E148D I-AniI enzyme. Right panels show the overlaid GFP fluorescence histograms of the cells
expressing the enzyme (mCherry
+ cells from the dot plots on the left side). The no LV histograms correspond to the mCherry negative population. (b)
Y2 I-AniI digestion profiles of the PCR amplicons containing the Y2 I-AniI target region obtained from the unsorted cells from panel (a). Full length
undigested DNA (UD), digest products (DPs). The positive control (‘‘C’’) consisted of PCR product directly amplified from reporter lentivirus. (c)
Sequence analysis of PCR amplicons from cells transduced at an moi of 12.5 from panel (a–b). Nucleotide insertions are indicated in blue. (GenBank
accession numbers: HQ432772 to HQ432804).
doi:10.1371/journal.pone.0016825.g009
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receptor for certain strains of HIV [24], and ZFNs have also been
designed that target hepatitis B virus [25]. While ZFNs are more
easily redirected toward desired sequences than HEs, the ZFNs
may also be less specific, raising concerns regarding off-target
cleavage and mutation of undesired genomic sites. We believe that
the highly specific HEs are likely to provide a more viable pathway
to ultimate clinical use, although formidable challenges remain in
retargeting them toward HIV sequences. Among these challenges
are the rapid mutation of HIV and the resulting diversity of HIV
sequences; these will likely require the use of multiple HIV-specific
HEs, each recognizing well-conserved targets. Targeting HEs to
the relevant long-lived cells comprising the HIV reservoir is also a
major issue, and will require significant improvements upon our
existing delivery systems. Nevertheless, our data demonstrate that
engineered HEs can specifically and efficiently target specific
sequences embedded into an integrated reporter lentivirus,
resulting in mutation and the inability to synthesize lentiviral
reporter-encoded protein. The results suggest that reengineering
HEs to target viral DNA sequences could be a viable strategy to
mutate integrated HIV provirus, thereby eliminating viral
replication and pathogenesis, effectively curing latently infected
cells.
Materials and Methods
Cell lines
Jurkat and HEp -2 cells were obtained from ATCC and
passaged in RPMI supplemented with 10% fetal bovine serum
(FBS), Sodium Pyruvate, glutamate and DMEM supplemented
with 10% FBS, respectively.
Lentiviral vector
pAniI-RS-TurboGFP was generated from pTurbo GFP (Evro-
gen) by removal of the start codon of GFP using the following
primers 59-CGGGATCCGAGAGCGACGAGAGCGGCCTG-
C-39 and 59-TGCTCCACGGTGGCGTTGCTGCGGATGAT-
C-39 and cloning BamHI-digested amplicon back into the BamHI-
XmnI digested pTurbo GFP, followed by cloning of the I-AniI
target sequence, using the primers 59-ATTCGCCACCATGGT-
GAGGAGGTTTCTCTGTAACG-39 and GATCCGTTACA-
GAGAAACCTCCTCACCATGGTGGCG-39, into the BamHI-
EcoRI-digested pTurbo GFP. A second start codon in the N-
terminal sequence of the GFP gene was also removed.
A lentiviral reporter vector (pRRL.SFFV.I-AniI-RS-GFP) was
constructed by subcloning the EcoRI (blunted)-XbaI fragment of
the plasmid pI-AniI-RS-TurboGFP containing the I-AniI reporter
site into klenow-treated Tth111I and SpeI sites of the pRRL.SFFV
vector derived from pRRLPGK-GFP[26]. pCVL.SFFV.Y2 I-
AniI.IRES.mCherry and pCVL.SFFV.E148D I-AniI.IRES.m-
Cherry were used to transduce cells in the experiments presented
in Fig. 1–4. pCVL.SFFV.Y2 I-AniI.2A.mCherry and pCVL.
SFFV.E148D I-AniI.2A.mCherry were the integrating lentiviral
vectors used for the transduction experiments presented in
Fig. 5–9. For transient expression of Y2-I-AniI, a lentiviral vector
with a short form of EF1a driving Y2 I-AniI.2A.mCherry was
constructed and used to produce integration deficient lentiviral
vector (IDLV). VSV-G-pseudotyped lentiviral vectors were
produced by transient transfection of 293T cells as described
elsewhere [27]. Lentiviral stocks were titrated by transducing
2610
5 cells with 2-fold increased volume of lentiviral supernatant
and determination of the number of transduced cells by flow
cytometry analysis for the fluorescent marker 3–4 days post-
transduction. The titer (ifu/ml) was calculated as {(number of
transduced cells x % fluorescent positive cells)/100}/volume of
viral supernatant used in ml.
Cell transduction
For HEp-2, 2610
5 cells per well were placed in one well of a12-
well plate and either left to adhere for 12–16 h before being
transduced with the lentivirus construct indicated, in 1 ml culture
medium containing 4 mg/ml polybrene. The next day, the
transduction medium was replaced with fresh culture medium
and incubated for 3–4 more days before GFP and/or mCherry
fluorescence analysis. Jurkat cells (2610
5 cells per well) were
transduced with the lentivirus vectors in 1 ml culture medium
containing 4 mg/ml polybrene, incubated at 37uC for 6 h
minimum in the transduction medium, 0.5–1 ml fresh medium
added and further incubated 3–4 days before analysis.
Construction of reporter target cell line
After transduction of the cells with the lentiviral reporter
pRRL.SFFV.AniI-RS-GFP, clones were isolated by limiting
dilution and fluorescence-activated cell sorting (FACS). Clones
were cultivated and assessed for GFP expression. The bulk cell line
was established by flow cytometric sorting of the GFP positive cell
population after transduction. No decrease of GFP expression was
observed after several months in culture (.2 months).
DNA analysis
Genomic DNA was isolated using the DNeasy Blood & Tissue
Kit (Qiagen) from either sorted cell populations or transduced cells
collected by trypsinization or centrifugation for adherent or non-
adherent cells, respectively. PCR amplification of the DNA
sequence containing the I-AniI target site was performed as
follows. Fifty ng of genomic DNA was used to amplify a 556 bp
DNA sequence containing the Y2 I-AniI recognition sequence
from the integrated pRRL.SFFV.AniI-RS-GFP lentivirus, using
Platinum Pfx DNA polymerase (Invitrogen), primers: 59-GGA-
AGCTTGCCAAACAGGATATCTGCGGTGAGC-39 and 59-
GACTAGTCGGGTAGGTGCCGAAGTGGTAGAAGC-39, and
the following program: 94uC 2 min., for 35 cycles 94uC 15 sec,
60uC 15 sec, 68uC 30 sec, then ended with 68uC 10 min.
For sequencing analysis, amplicons were subsequently purified
after electrophoresis on a 1% agarose gel, using QIAquick gel
extraction kit or cleaned up using QIAquick PCR purification kit
(Qiagen) per the manufacturer’s recommendations. The purified
PCR amplicons were cloned into PCRH4Blunt-TOPOH vector
using Zero BluntHTOPOH PCR Cloning kit for sequencing
(Invitrogen) as per manufacturer’s recommendations. Briefly, 5 ml
of purified PCR product were ligated into the vector during a
20 min incubation at room temperature, and transformed into
One ShotH TOP10 competent cells. Transformants were selected
by plating onto LB-agar plate containing 50 mg/ml Kanamycin.
Colonies were grown overnight in LB containing 50 mg/ml
Kanamycin. Plasmid DNA was isolated using the PureLink Quick
plasmid miniprep kit (Invitrogen) as per manufacturer’s protocol.
The presence of an insert was confirmed by EcoRI digest of the
plasmid DNA, followed by electrophoresis on 1% agarose gel. The
plasmid DNAs were also subjected to in vitro Y2 I-AniI digest using
purified Y2 I-AniI enzyme as described by Takeuchi et al [8],
followed by electrophoresis onto 2% agarose gel. After staining the
DNA with ethidium bromide solution, gel images were captured
using an AlphaImagerTM 3400 (AlphInnotech) system and the
intensity (I) of the DNA fragments determined using AlphaEaseFC
software tools. The percent of undigested full length DNA was cal-
culated as follows: [I full length undigested DNA/(Ifull length undigested DNA+
Idigested products)]x100. The insert of each isolated plasmid was
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(sequence) or M13F (sequence) and BigDye sequencing reaction
(FHCRC, Shared resources) using the program 96uC 1 min., for 25
cycles 96uC 10 sec, 50uC 5 sec, 60uC 4 min.
Flow cytometry
To analyze GFP fluorescence in the HEp-2 reporter cell lines,
cells were treated with 1 mM MG132 (Calbiochem) for 6 h or
otherwise indicated, and kept overnight at 4uC in 1% parafor-
maldehyde in PBS prior to analysis on a BD LSRII flow
cytometer. GFP fluorescence analysis in the reporter Jurkat cell
line was performed on a BD LSRII flow cytometer immediately
after 6 h incubation with 1 mM MG132. For cell death analysis,
cells were collected by trypsinization, washed in PBS, and then
assayed for cell viability using Live/Dead cell stain kit (Invitrogen,
as per the manufacturer’s recommendations) which stains dead
cells with compromised membranes after reaction with the amine-
reactive fluorescent dye (Pacific blue). Apoptosis was also evaluated
by staining for active-caspase-3 as previously described [28] with
the following modifications. After fixation with paraformaldehyde,
cells were permeabilized with 0.1% Triton X-100 for 10 min and
stained with FITC conjugated anti-active caspase-3 antibody
diluted in 50 ml 0.1% Triton X-100 1% BSA solution at room
temperature.
Cell sorting for mCherry fluorescence was performed on a BD
FACSAria II and for GFP fluorescence on a BD FACSVantage
(FHCRC, shared resources).
All the data were analyzed using FlowJo software (TreeStar).
c-H2AX immmunofluorescence
Cells (0.5–1610
6) were grown overnight on glass coverslips
prior to staining c-H2AX as described previously [29]. Briefly, the
cells were fixed with 2% paraformaldehyde in PBS for 20 min,
permeabilized with 0.5% Triton X-100 in PBS for 10 min, and
incubated in blocking buffer (PBS +3% bovine serum albumin
+0.1% Tween 20) for 30 min. Anti-c-H2AX (JBW301, 1:1,000;
Upstate) and FITC conjugated anti-mouse (1:1000: Jackson
ImmunoResearch) were used and nuclei were counterstained with
49,6-diamidino-2-phenylindole (1 mg/mL). Coverslips were mounted
on slides in Vectashield (Vector Laboratories). Images were acquired
using a microscope (TE2000, Nikon) equipped with a 40x immersion
objective (1.3 numerical aperture) and a CCD camera (CoolSNAP
ES, Photometrics) and analyzed using MetaVue (Universal Imaging).
At least 330 cells were scored for the presence of foci.
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